(Q41471703)

English

The risk of pneumococcal infections after immunization with pneumococcal conjugate vaccine compared to non-vaccinated inflammatory arthritis patients

scientific article published on 6 February 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 October 2017

The risk of pneumococcal infections after immunization with pneumococcal conjugate vaccine compared to non-vaccinated inflammatory arthritis patients (English)

1 reference

Europe PubMed Central

1 October 2017

pneumococcal conjugate vaccine

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25656734%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Ingemar F. Petersson

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25656734%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Meliha C Kapetanovic

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25656734%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

J Nagel

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25656734%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

P Geborek

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25656734%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

T Saxne

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25656734%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

G Jönsson

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25656734%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

J-Å Nilsson

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25656734%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

publication date

6 February 2015

1 reference

Europe PubMed Central

1 October 2017

Scandinavian Journal of Rheumatology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25656734%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

44

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25656734%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25656734%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

271-279

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25656734%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2014.984754

21 January 2018

Risk of invasive pneumococcal disease in people admitted to hospital with selected immune-mediated diseases: record linkage cohort analyses

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2014.984754

21 January 2018

Increased mortality in ankylosing spondylitis is related to disease activity.

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2014.984754

21 January 2018

The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2014.984754

21 January 2018

Trends in serious infections in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2014.984754

21 January 2018

Predictors of infection in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2014.984754

21 January 2018

The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2014.984754

21 January 2018

Identification of new risk factors for pneumonia: population-based case-control study

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2014.984754

21 January 2018

Vaccinations in patients with immune-mediated inflammatory diseases

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2014.984754

21 January 2018

Serious infections in patients with ankylosing spondylitis with and without TNF blockers: a systematic review and meta-analysis of randomised placebo-controlled trials

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2014.984754

21 January 2018

Development and validation of a risk score for serious infection in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2014.984754

21 January 2018

Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2014.984754

21 January 2018

Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA.

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2014.984754

21 January 2018

Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2014.984754

21 January 2018

Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2014.984754

21 January 2018

Efficacy of pneumococcal vaccination in adults: a meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2014.984754

21 January 2018

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2014.984754

21 January 2018

Prevenar experience

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2014.984754

21 January 2018

Carried pneumococci in Massachusetts children: the contribution of clonal expansion and serotype switching.

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2014.984754

21 January 2018

Pre- and post-conjugate vaccine epidemiology of pneumococcal serotype 6C invasive disease and carriage within Navajo and White Mountain Apache communities.

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2014.984754

21 January 2018

Increase in serotype 6C pneumococcal carriage, United Kingdom.

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2014.984754

21 January 2018

Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2014.984754

21 January 2018

Pneumococcal antibody levels after pneumovax in patients with rheumatoid arthritis on methotrexate

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2014.984754

21 January 2018

Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2014.984754

21 January 2018

Prevalence and incidence of rheumatoid arthritis in southern Sweden 2008 and their relation to prescribed biologics

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2014.984754

21 January 2018

Prevalence of spondyloarthritis and its subtypes in southern Sweden

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2014.984754

21 January 2018

Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2014.984754

21 January 2018

Small-area variations in sales of TNF inhibitors in Sweden between 2000 and 2009.

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2014.984754

21 January 2018

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2014.984754

21 January 2018

Persistence of antibody response 1.5 years after vaccination using 7-valent pneumococcal conjugate vaccine in patients with arthritis treated with different antirheumatic drugs

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2014.984754

21 January 2018

Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010–2012

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2014.984754

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41471703&oldid=1922048924"